Package 71610-576-30

{"route": ["ORAL"], "spl_id": "a21c94b7-5512-4999-bb4b-308c6008569c", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993518", "993536"], "spl_set_id": ["5f8b3313-0286-499f-9235-02cdc0eb063b"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71610-576-30)", "package_ndc": "71610-576-30", "marketing_start_date": "20210811"}, {"sample": false, "description": "90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71610-576-60)", "package_ndc": "71610-576-60", "marketing_start_date": "20210701"}, {"sample": false, "description": "180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71610-576-80)", "package_ndc": "71610-576-80", "marketing_start_date": "20210701"}], "brand_name": "Bupropion Hydrochloride SR", "product_id": "71610-576_a21c94b7-5512-4999-bb4b-308c6008569c", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "71610-576", "generic_name": "bupropion hydrochloride", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "SR", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA205794", "marketing_category": "ANDA", "marketing_start_date": "20210415", "listing_expiration_date": "20261231"}